BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33961721)

  • 1. Radiotherapy and the immune system: More than just immune suppression.
    Rückert M; Flohr AS; Hecht M; Gaipl US
    Stem Cells; 2021 Sep; 39(9):1155-1165. PubMed ID: 33961721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations.
    Colton M; Cheadle EJ; Honeychurch J; Illidge TM
    Radiat Oncol; 2020 Nov; 15(1):254. PubMed ID: 33148287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy combined with immunotherapy: the dawn of cancer treatment.
    Zhang Z; Liu X; Chen D; Yu J
    Signal Transduct Target Ther; 2022 Jul; 7(1):258. PubMed ID: 35906199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy.
    Zhen W; Weichselbaum RR; Lin W
    Adv Mater; 2023 May; 35(21):e2206370. PubMed ID: 36524978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership.
    Chajon E; Castelli J; Marsiglia H; De Crevoisier R
    Crit Rev Oncol Hematol; 2017 Mar; 111():124-132. PubMed ID: 28259287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining radiotherapy and cancer immunotherapy: a paradigm shift.
    Formenti SC; Demaria S
    J Natl Cancer Inst; 2013 Feb; 105(4):256-65. PubMed ID: 23291374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
    Shahabi V; Postow MA; Tuck D; Wolchok JD
    Am J Clin Oncol; 2015 Feb; 38(1):90-7. PubMed ID: 25616204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune modulatory effects of radiotherapy as basis for well-reasoned radioimmunotherapies.
    Rückert M; Deloch L; Fietkau R; Frey B; Hecht M; Gaipl US
    Strahlenther Onkol; 2018 Jun; 194(6):509-519. PubMed ID: 29500551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced tumor immune microenvironments and potential targets for combination therapy.
    Guo S; Yao Y; Tang Y; Xin Z; Wu D; Ni C; Huang J; Wei Q; Zhang T
    Signal Transduct Target Ther; 2023 May; 8(1):205. PubMed ID: 37208386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer immunotherapy: how low-level ionizing radiation can play a key role.
    Janiak MK; Wincenciak M; Cheda A; Nowosielska EM; Calabrese EJ
    Cancer Immunol Immunother; 2017 Jul; 66(7):819-832. PubMed ID: 28361232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
    Darragh LB; Oweida AJ; Karam SD
    Front Immunol; 2018; 9():3154. PubMed ID: 30766539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Immunostimulatory Effects of Radiation Therapy Improves the Outcomes of Patients With Advanced NSCLC Receiving Immunotherapy.
    D'Andrea MA; Reddy GK
    Am J Clin Oncol; 2020 Mar; 43(3):218-228. PubMed ID: 31842114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect.
    Rodríguez-Ruiz ME; Vanpouille-Box C; Melero I; Formenti SC; Demaria S
    Trends Immunol; 2018 Aug; 39(8):644-655. PubMed ID: 30001871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy and immunotherapy: a beneficial liaison?
    Weichselbaum RR; Liang H; Deng L; Fu YX
    Nat Rev Clin Oncol; 2017 Jun; 14(6):365-379. PubMed ID: 28094262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies and molecular mechanism of radiotherapy combined with immunotherapy in colorectal cancer.
    Jin Y; Jiang J; Mao W; Bai M; Chen Q; Zhu J
    Cancer Lett; 2024 Jun; 591():216858. PubMed ID: 38621460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune targets in the tumor microenvironment treated by radiotherapy.
    Ozpiskin OM; Zhang L; Li JJ
    Theranostics; 2019; 9(5):1215-1231. PubMed ID: 30867826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy and radiotherapy].
    Bockel S; Antoni D; Deutsch É; Mornex F
    Cancer Radiother; 2017 May; 21(3):244-255. PubMed ID: 28522277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local Interleukin-12 Treatment Enhances the Efficacy of Radiation Therapy by Overcoming Radiation-Induced Immune Suppression.
    Yu CF; Chang CH; Wang CC; Hong JH; Chiang CS; Chen FH
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.
    Eckert F; Zwirner K; Boeke S; Thorwarth D; Zips D; Huber SM
    Front Immunol; 2019; 10():407. PubMed ID: 30930892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radiotherapy in the age of immunotherapy.
    Sato H; Demaria S; Ohno T
    Jpn J Clin Oncol; 2021 Apr; 51(4):513-522. PubMed ID: 33561212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.